Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 61

1.

Mitochondrial DNA G15927A and G15928A variations in patients with multiple sclerosis.

Andalib S, Talebi M, Sakhinia E, Farhoudi M, Sadeghi-Bazargani H, Masoudian N, Michel TM, Vafaee MS, Gjedde A.

Mult Scler Relat Disord. 2018 Sep 7;27:9-12. doi: 10.1016/j.msard.2018.09.004. [Epub ahead of print]

PMID:
30292021
2.

Impact of Premorbid Malnutrition and Dysphagia on Ischemic Stroke Outcome in Elderly Patients: A Community-Based Study.

Aliasghari F, Izadi A, Khalili M, Farhoudi M, Ahmadiyan S, Deljavan R.

J Am Coll Nutr. 2018 Sep 25:1-9. doi: 10.1080/07315724.2018.1510348. [Epub ahead of print]

PMID:
30252628
3.

Prognostic factors in patients with acute ischemic stroke treated with intravenous tissue plasminogen activator: The first study among Iranian patients.

Sadeghi-Hokmabadi E, Yazdchi M, Farhoudi M, Sadeghi H, Taheraghdam A, Rikhtegar R, Aliyar H, Mohammadi-Fallah S, Asadi R, Mehdizadeh-Far E, Ghaemian N.

Iran J Neurol. 2018 Jan 5;17(1):31-37.

4.

Intranasal cerebrolysin improves cognitive function and structural synaptic plasticity in photothrombotic mouse model of medial prefrontal cortex ischemia.

Sadigh-Eteghad S, Geranmayeh MH, Majdi A, Salehpour F, Mahmoudi J, Farhoudi M.

Neuropeptides. 2018 Oct;71:61-69. doi: 10.1016/j.npep.2018.07.002. Epub 2018 Jul 10.

PMID:
30054019
5.

Stroke in-hospital survival and its predictors: the first results from Tabriz Stroke Registry of Iran.

Deljavan R, Farhoudi M, Sadeghi-Bazargani H.

Int J Gen Med. 2018 Jun 19;11:233-240. doi: 10.2147/IJGM.S158296. eCollection 2018.

6.

Spectrophotometric analysis of thrombolytic activity: SATA assay.

Zamanlu M, Eskandani M, Mohammadian R, Entekhabi N, Rafi M, Farhoudi M.

Bioimpacts. 2018;8(1):31-38. doi: 10.15171/bi.2018.05. Epub 2017 Nov 1.

7.

An In Vivo Assessment of Blood-Brain Barrier Disruption in a Rat Model of Ischemic Stroke.

Panahpour H, Farhoudi M, Omidi Y, Mahmoudi J.

J Vis Exp. 2018 Mar 11;(133). doi: 10.3791/57156.

PMID:
29578526
8.

Fluid-structure interaction of patient-specific Circle of Willis with aneurysm: Investigation of hemodynamic parameters.

Jahed M, Ghalichi F, Farhoudi M.

Biomed Mater Eng. 2018;29(3):357-368. doi: 10.3233/BME-181732.

PMID:
29578465
9.

Neurotrophic factors hold promise for the future of Parkinson's disease treatment: is there a light at the end of the tunnel?

Nasrolahi A, Mahmoudi J, Akbarzadeh A, Karimipour M, Sadigh-Eteghad S, Salehi R, Farhoudi M.

Rev Neurosci. 2018 Jul 26;29(5):475-489. doi: 10.1515/revneuro-2017-0040.

PMID:
29305570
10.

Stroke subtypes, risk factors and mortality rate in northwest of Iran.

Farhoudi M, Mehrvar K, Sadeghi-Bazargani H, Hashemilar M, Seyedi-Vafaee M, Sadeghi-Hokmabad E, Rikhtegar R, Saber-Maroof B, Abutalebi M, Rezaei M, Vaferi S, Aghili A, Ebrahimi O.

Iran J Neurol. 2017 Jul 6;16(3):112-117.

11.

No evidence of association between optic neuritis and secondary LHON mtDNA mutations in patients with multiple sclerosis.

Andalib S, Talebi M, Sakhinia E, Farhoudi M, Sadeghi-Bazargani H, Masoudian N, Vafaee MS, Gjedde A.

Mitochondrion. 2017 Sep;36:182-185. doi: 10.1016/j.mito.2017.08.005. Epub 2017 Aug 10.

PMID:
28802665
12.

Recent advances in targeted delivery of tissue plasminogen activator for enhanced thrombolysis in ischaemic stroke.

Zamanlu M, Farhoudi M, Eskandani M, Mahmoudi J, Barar J, Rafi M, Omidi Y.

J Drug Target. 2018 Feb;26(2):95-109. doi: 10.1080/1061186X.2017.1365874. Epub 2017 Aug 25.

PMID:
28796540
13.

Transcranial low-level laser therapy improves brain mitochondrial function and cognitive impairment in D-galactose-induced aging mice.

Salehpour F, Ahmadian N, Rasta SH, Farhoudi M, Karimi P, Sadigh-Eteghad S.

Neurobiol Aging. 2017 Oct;58:140-150. doi: 10.1016/j.neurobiolaging.2017.06.025. Epub 2017 Jul 6.

PMID:
28735143
14.

Atorvastatin inhibits cholesterol-induced caspase-3 cleavage through down-regulation of p38 and up-regulation of Bcl-2 in the rat carotid artery.

Bayatmakoo R, Rashtchizadeh N, Yaghmaei P, Farhoudi M, Karimi P.

Cardiovasc J Afr. 2017 Sep/Oct 23;28(5):298-303. doi: 10.5830/CVJA-2017-005. Epub 2017 May 5.

15.

Combination therapy using evening primrose oil and electrical stimulation to improve nerve function following a crush injury of sciatic nerve in male rats.

Badri O, Shahabi P, Abdolalizadeh J, Alipour MR, Veladi H, Farhoudi M, Zak MS.

Neural Regen Res. 2017 Mar;12(3):458-463. doi: 10.4103/1673-5374.202927.

16.

Renal Dysfunction Is an Independent Risk Factor for Poor Outcome in Acute Ischemic Stroke Patients Treated with Intravenous Thrombolysis: A New Cutoff Value.

Sadeghi-Hokmabadi E, Baş DF, Farhoudi M, Taheraghdam A, Savadi Oskouei D, Yazdchi M, Hashemilar M, Uzuner N, Mirnour R, Colak E, Özdemir AÖ.

Stroke Res Treat. 2017;2017:2371956. doi: 10.1155/2017/2371956. Epub 2017 Jan 3.

17.

Stem Cells as a Promising Tool for the Restoration of Brain Neurovascular Unit and Angiogenic Orientation.

Geranmayeh MH, Nourazarian A, Avci ÇB, Rahbarghazi R, Farhoudi M.

Mol Neurobiol. 2017 Dec;54(10):7689-7705. doi: 10.1007/s12035-016-0286-4. Epub 2016 Nov 14. Review.

PMID:
27844280
18.

Intravenous recombinant tissue plasminogen activator for acute ischemic stroke: a feasibility and safety study.

Sadeghi-Hokmabadi E, Farhoudi M, Taheraghdam A, Hashemilar M, Savadi-Osguei D, Rikhtegar R, Mehrvar K, Sharifipour E, Youhanaee P, Mirnour R.

Int J Gen Med. 2016 Oct 25;9:361-367. eCollection 2016.

19.

The correlation between Toxoplasma gondii infection and Parkinson's disease: a case-control study.

Mahami Oskouei M, Hamidi F, Talebi M, Farhoudi M, Taheraghdam AA, Kazemi T, Sadeghi-Bazargani H, Fallah E.

J Parasit Dis. 2016 Sep;40(3):872-6. doi: 10.1007/s12639-014-0595-3. Epub 2014 Oct 14.

20.

The interplay of microRNAs and post-ischemic glutamate excitotoxicity: an emergent research field in stroke medicine.

Majdi A, Mahmoudi J, Sadigh-Eteghad S, Farhoudi M, Shotorbani SS.

Neurol Sci. 2016 Nov;37(11):1765-1771. Epub 2016 Jun 27. Review.

PMID:
27350638
21.

Toxoplasmosis and Alzheimer: can Toxoplasma gondii really be introduced as a risk factor in etiology of Alzheimer?

Mahami-Oskouei M, Hamidi F, Talebi M, Farhoudi M, Taheraghdam AA, Kazemi T, Sadeghi-Bazargani H, Fallah E.

Parasitol Res. 2016 Aug;115(8):3169-74. doi: 10.1007/s00436-016-5075-5. Epub 2016 Apr 23.

PMID:
27106237
22.

Lack of association between mitochondrial DNA G15257A and G15812A variations and multiple sclerosis.

Andalib S, Talebi M, Sakhinia E, Farhoudi M, Sadeghi-Bazargani H, Gjedde A.

J Neurol Sci. 2015 Sep 15;356(1-2):102-6. doi: 10.1016/j.jns.2015.06.022. Epub 2015 Jun 12.

PMID:
26233806
23.

Mitochondrial DNA T4216C and A4917G variations in multiple sclerosis.

Andalib S, Talebi M, Sakhinia E, Farhoudi M, Sadeghi-Bazargani H, Gjedde A.

J Neurol Sci. 2015 Sep 15;356(1-2):55-60. doi: 10.1016/j.jns.2015.04.050. Epub 2015 May 7.

PMID:
26201854
24.

Investigation of IL-21 gene polymorphisms (rs2221903, rs2055979) in cases with multiple sclerosis of Azerbaijan, Northwest Iran.

Gharibi T, Kazemi T, Aliparasti MR, Farhoudi M, Almasi S, Dehghanzadeh R, Seyfizadeh N, Babaloo Z.

Am J Clin Exp Immunol. 2015 Jul 5;4(1):7-14. eCollection 2015.

25.

Antidepressant-like effect of modafinil in mice: Evidence for the involvement of the dopaminergic neurotransmission.

Mahmoudi J, Farhoudi M, Talebi M, Sabermarouf B, Sadigh-Eteghad S.

Pharmacol Rep. 2015 Jun;67(3):478-84. doi: 10.1016/j.pharep.2014.11.005. Epub 2014 Nov 23.

PMID:
25933957
26.

Ketogenic Diet Provides Neuroprotective Effects against Ischemic Stroke Neuronal Damages.

Shaafi S, Mahmoudi J, Pashapour A, Farhoudi M, Sadigh-Eteghad S, Akbari H.

Adv Pharm Bull. 2014 Dec;4(Suppl 2):479-81. doi: 10.5681/apb.2014.071. Epub 2014 Dec 31.

27.

Association of IL-13 single nucleotide polymorphisms in Iranian patients to multiple sclerosis.

Seyfizadeh N, Kazemi T, Farhoudi M, Aliparasti MR, Sadeghi-Bazargani H, Almasi S, Babaloo Z.

Am J Clin Exp Immunol. 2014 Dec 5;3(3):124-9. eCollection 2014.

28.

The role of Th17 cells in patients with relapsing-remitting multiple sclerosis: interleukin-17A and interleukin-17F serum levels.

Babaloo Z, Aliparasti MR, Babaiea F, Almasi S, Baradaran B, Farhoudi M.

Immunol Lett. 2015 Apr;164(2):76-80. doi: 10.1016/j.imlet.2015.01.001. Epub 2015 Jan 24.

PMID:
25625963
29.

Amyloid-beta: a crucial factor in Alzheimer's disease.

Sadigh-Eteghad S, Sabermarouf B, Majdi A, Talebi M, Farhoudi M, Mahmoudi J.

Med Princ Pract. 2015;24(1):1-10. doi: 10.1159/000369101. Epub 2014 Nov 27. Review.

30.

The first international and the sixth national Iranian stroke congress event report.

Farhoudi M, Mehrvar K, Kavandi H, Aslanabadi A.

Iran J Neurol. 2014 Jul 4;13(3):193-4. No abstract available.

31.

Eligibility assessment for intravenous thrombolytic therapy in acute ischemic stroke patients; evaluating barriers for implementation.

Ayromlou H, Soleimanpour H, Farhoudi M, Taheraghdam A, Sadeghi Hokmabadi E, Rajaei Ghafouri R, Najafi Nashali M, Sharifipour E, Mostafaei S, Altafi D.

Iran Red Crescent Med J. 2014 May;16(5):e11284. doi: 10.5812/ircmj.11284. Epub 2014 May 5.

32.

Different patterns of brain activation in normal aging and Alzheimer's disease from cognitional sight: meta analysis using activation likelihood estimation.

Sadigh-Eteghad S, Majdi A, Farhoudi M, Talebi M, Mahmoudi J.

J Neurol Sci. 2014 Aug 15;343(1-2):159-66. doi: 10.1016/j.jns.2014.05.066. Epub 2014 Jun 6.

PMID:
24950901
33.

Does lipoic acid consumption affect the cytokine profile in multiple sclerosis patients: a double-blind, placebo-controlled, randomized clinical trial.

Khalili M, Azimi A, Izadi V, Eghtesadi S, Mirshafiey A, Sahraian MA, Motevalian A, Norouzi A, Sanoobar M, Eskandari G, Farhoudi M, Amani F.

Neuroimmunomodulation. 2014;21(6):291-6. doi: 10.1159/000356145. Epub 2014 May 6.

PMID:
24821457
34.

Early and intermediate prognosis of intravenous thrombolytic therapy in acute ischemic stroke subtypes according to the causative classification of stroke system.

Pashapour A, Atalu A, Farhoudi M, Taheraghdam AA, Sadeghi Hokmabadi E, Sharifipour E, Najafineshli M.

Pak J Med Sci. 2013 Jan;29(1):181-6. doi: 10.12669/pjms.291.2897.

35.

Dampening of Serotonergic System through 5HT1A Receptors is a Promising Target for Treatment of Levodopa Induced Motor Problems.

Mahmoudi J, Farhoudi M, Reyhani-Rad S, Sadigh-Eteghad S.

Adv Pharm Bull. 2013;3(2):439-41. doi: 10.5681/apb.2013.071. Epub 2013 Aug 20.

36.

Erythrocyte membrane fatty acids in multiple sclerosis patients and hot-nature dietary intervention with co-supplemented hemp-seed and evening-primrose oils.

Rezapour-Firouzi S, Arefhosseini SR, Ebrahimi-Mamaghani M, Farhoudi M, Baradaran B, Ali TM, Zamani F.

Afr J Tradit Complement Altern Med. 2013 Oct 3;10(6):519-27. eCollection 2013.

37.

Serum iron and ferritin level in idiopathic Parkinson.

Farhoudi M, Taheraghdam A, Farid GA, Talebi M, Pashapou A, Majidi J, Goldust M.

Pak J Biol Sci. 2012 Nov 15;15(22):1094-7.

PMID:
24261127
38.

Immunomodulatory and therapeutic effects of Hot-nature diet and co-supplemented hemp seed, evening primrose oils intervention in multiple sclerosis patients.

Rezapour-Firouzi S, Arefhosseini SR, Mehdi F, Mehrangiz EM, Baradaran B, Sadeghihokmabad E, Mostafaei S, Fazljou SM, Torbati MA, Sanaie S, Zamani F.

Complement Ther Med. 2013 Oct;21(5):473-80. doi: 10.1016/j.ctim.2013.06.006. Epub 2013 Jul 25.

PMID:
24050582
39.

Evaluation of iron serum level in Alzheimer disease.

Goldust M, Taheraghdam A, Talebi M, Farhoudi M, Majidi J.

J Pak Med Assoc. 2013 Feb;63(2):300. No abstract available.

40.

Effects of Levodopa loaded chitosan nanoparticles on cell viability and caspase-3 expression in PC12 neural like cells.

Sadigh-Eteghad S, Talebi M, Farhoudi M, Mahmoudi J, Reyhani B.

Neurosciences (Riyadh). 2013 Jul;18(3):281-3. No abstract available.

PMID:
23887222
41.

Quantitative evaluation of CXCL8 and its receptors (CXCR1 and CXCR2) gene expression in Iranian patients with multiple sclerosis.

Almasi S, Aliparasti MR, Farhoudi M, Babaloo Z, Baradaran B, Zamani F, Sadeghi-Bazargani H, Mostafaei S, Hokmabadi ES.

Immunol Invest. 2013;42(8):737-48. doi: 10.3109/08820139.2013.812652. Epub 2013 Jul 22.

PMID:
23876169
42.

What are the most important barriers for thrombolytic therapy in ischemic stroke patients?

Ayromlou H, Soleimanpour H, Farhoudi M, Sadeghi-Hokmabadi E, Rajaei Ghafouri R, Sharifipour E, Mostafaei S, Najafi Nashali M.

Int J Stroke. 2013 Jun;8(4):E7. doi: 10.1111/ijs.12093. No abstract available.

PMID:
23692492
43.

Association of Expanded Disability Status Scale and Cytokines after Intervention with Co-supplemented Hemp Seed, Evening Primrose Oils and Hot-natured Diet in Multiple Sclerosis Patients(♦).

Rezapour-Firouzi S, Arefhosseini SR, Farhoudi M, Ebrahimi-Mamaghani M, Rashidi MR, Torbati MA, Baradaran B.

Bioimpacts. 2013;3(1):43-7. doi: 10.5681/bi.2013.001. Epub 2012 Oct 28.

44.

Multiple sclerosis and mitochondrial gene variations: a review.

Andalib S, Talebi M, Sakhinia E, Farhoudi M, Sadeghi-Bazargani H, Motavallian A, Pilehvar-Soltanahmadi Y.

J Neurol Sci. 2013 Jul 15;330(1-2):10-5. doi: 10.1016/j.jns.2013.04.018. Epub 2013 May 10. Review.

PMID:
23669867
45.

Effect of IMOD™ on the inflammatory process after acute ischemic stroke: a randomized clinical trial.

Farhoudi M, Najafi-Nesheli M, Hashemilar M, Mahmoodpoor A, Sharifipour E, Baradaran B, Taheraghdam A, Savadi-Oskouei D, Sadeghi-Bazargani H, Sadeghi-Hokmabadi E, Akbari H, Rikhtegar R.

Daru. 2013 Mar 20;21(1):26. doi: 10.1186/2008-2231-21-26.

46.

A report of a probable case of familial Guillain Barre syndrome.

Barzegar M, Rouhi AH, Farhoudi M, Sardashti S.

Ann Indian Acad Neurol. 2012 Oct;15(4):299-302. doi: 10.4103/0972-2327.104341.

47.

Comparison of blood flow velocity through the internal carotid artery based on Doppler ultrasound and numerical simulation.

Hassani-Ardekani H, Ghalichi F, Niroomand-Oscuii H, Farhoudi M, Tarzmani MK.

Australas Phys Eng Sci Med. 2012 Dec;35(4):413-22. doi: 10.1007/s13246-012-0162-0. Epub 2012 Sep 28.

PMID:
23055127
48.

Association of apolipoprotein E epsilon 4 allele with sporadic late onset Alzheimer`s disease. A meta-analysis.

Sadigh-Eteghad S, Talebi M, Farhoudi M.

Neurosciences (Riyadh). 2012 Oct;17(4):321-6. Review.

PMID:
23022896
49.

OPLS statistical model versus linear regression to assess sonographic predictors of stroke prognosis.

Vajargah KF, Sadeghi-Bazargani H, Mehdizadeh-Esfanjani R, Savadi-Oskouei D, Farhoudi M.

Neuropsychiatr Dis Treat. 2012;8:387-92. doi: 10.2147/NDT.S33991. Epub 2012 Aug 30.

50.

Cranioplasty in medieval Persia and the potential spread of this knowledge to Europe.

Shoja MM, Agutter PS, Loukas M, Shokouhi G, Khalili M, Farhoudi M, Tubbs RS.

Childs Nerv Syst. 2012 Dec;28(12):1993-6. doi: 10.1007/s00381-012-1876-8.

PMID:
22940849

Supplemental Content

Loading ...
Support Center